Eli Lilly plans large commitment to combat diabetes in Mexico

The drugmaker Eli Lilly and Company plans to invest 30 million dollars over the next five years to help fight chronic diseases in Brazil, South Africa, India and Mexico.It is estimated that direct and indirect costs of diabetes in Mexico totaled $ 778 million a year, including capital expenditures for medical treatments and costs related to complications of the disease, estimated the drug in a statement.
Currently, Mexico is the ninth highest incidence of diabetes in the world, with about 10 million people affected by the disease in the adult group 20 to 79 years.Read Article